AGLE
Aeglea Biotherapeutics, Inc.
CFO Jonathan Alspaugh bought $156K of Aeglea Biotherapeutics, Inc.
Bought$156,000
$2.08Price
75,000Shares
+83%Stake
What AGLE did for a copier
Prices for AGLE after this filing aren't in yet.
Jonathan Alspaugh's record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Mar 11. Filed Tue, Mar 15, 2:30 PM ET, during the session. Not investment advice.